Literature DB >> 30355627

Enhanced CRFR1-Dependent Regulation of a Ventral Tegmental Area to Prelimbic Cortex Projection Establishes Susceptibility to Stress-Induced Cocaine Seeking.

Oliver Vranjkovic1, Erik C Van Newenhizen1, Michael E Nordness1, Jordan M Blacktop1, Luke A Urbanik1, Jacob C Mathy1, Jayme R McReynolds1, Anna M Miller1, Elizabeth M Doncheck1, Tyler M Kloehn1, Gwen S Stinnett2, Clayton H Gerndt1, Kyle D Ketchesin2, David A Baker1, Audrey F Seasholtz2, John R Mantsch3.   

Abstract

The ability of stress to trigger cocaine seeking in humans and rodents is variable and is determined by the amount and pattern of prior drug use. This study examined the role of a corticotropin releasing factor (CRF)-regulated dopaminergic projection from the ventral tegmental area (VTA) to the prelimbic cortex in shock-induced cocaine seeking and its recruitment under self-administration conditions that establish relapse vulnerability. Male rats with a history of daily long-access (LgA; 14 × 6 h/d) but not short-access (ShA; 14 × 2 h/d) self-administration showed robust shock-induced cocaine seeking. This was associated with a heightened shock-induced prelimbic cortex Fos response and activation of cholera toxin b retro-labeled VTA neurons that project to the prelimbic cortex. Chemogenetic inhibition of this pathway using a dual virus intersectional hM4Di DREADD (designer receptor exclusively activated by designer drug) based approach prevented shock-induced cocaine seeking. Both shock-induced reinstatement and the prelimbic cortex Fos response were prevented by bilateral intra-VTA injections of the CRF receptor 1 (CRFR1) antagonist, antalarmin. Moreover, pharmacological disconnection of the CRF-regulated dopaminergic projection to the prelimbic cortex by injection of antalarmin into the VTA in one hemisphere and the D1 receptor antagonist, SCH23390, into the prelimbic cortex of the contralateral hemisphere prevented shock-induced cocaine seeking. Finally, LgA, but not ShA, cocaine self-administration resulted in increased VTA CRFR1 mRNA levels as measured using in situ hybridization. Altogether, these findings suggest that excessive cocaine use may establish susceptibility to stress-induced relapse by recruiting CRF regulation of a stressor-responsive mesocortical dopaminergic pathway.SIGNIFICANCE STATEMENT Understanding the neural pathways and mechanisms through which stress triggers relapse to cocaine use is critical for the development of more effective treatment approaches. Prior work has demonstrated a critical role for the neuropeptide corticotropin releasing factor (CRF) in stress-induced cocaine seeking. Here we provide evidence that stress-induced reinstatement in a rat model of relapse is mediated by a CRF-regulated dopaminergic projection from the ventral tegmental area (VTA) that activates dopamine D1 receptors in the prelimbic cortex. Moreover, we report that this pathway may be recruited as a result of daily cocaine self-administration under conditions of extended drug access/heightened drug intake, likely as a result of increased CRFR1 expression in the VTA, thereby promoting susceptibility to stress-induced cocaine seeking.
Copyright © 2018 the authors 0270-6474/18/3810658-15$15.00/0.

Entities:  

Keywords:  CRF; cocaine; dopamine; prefrontal; reinstatement; stress

Mesh:

Substances:

Year:  2018        PMID: 30355627      PMCID: PMC6290294          DOI: 10.1523/JNEUROSCI.2080-18.2018

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  52 in total

1.  Frequency of recent cocaine and alcohol use affects drug craving and associated responses to stress and drug-related cues.

Authors:  Helen C Fox; Makram Talih; Robert Malison; George M Anderson; Mary Jeanne Kreek; Rajita Sinha
Journal:  Psychoneuroendocrinology       Date:  2005-10       Impact factor: 4.905

2.  Selective activation of mesocortical DA system by stress.

Authors:  A M Thierry; J P Tassin; G Blanc; J Glowinski
Journal:  Nature       Date:  1976-09-16       Impact factor: 49.962

3.  Stress selectively increases fos protein in dopamine neurons innervating the prefrontal cortex.

Authors:  A Y Deutch; M C Lee; M H Gillham; D A Cameron; M Goldstein; M J Iadarola
Journal:  Cereb Cortex       Date:  1991 Jul-Aug       Impact factor: 5.357

Review 4.  Stress-Induced Reinstatement of Drug Seeking: 20 Years of Progress.

Authors:  John R Mantsch; David A Baker; Douglas Funk; Anh D Lê; Yavin Shaham
Journal:  Neuropsychopharmacology       Date:  2015-05-15       Impact factor: 7.853

5.  CRF-R2 and the heterosynaptic regulation of VTA glutamate during reinstatement of cocaine seeking.

Authors:  Courtney L Williams; William C Buchta; Arthur C Riegel
Journal:  J Neurosci       Date:  2014-07-30       Impact factor: 6.167

6.  Stress in the daily lives of cocaine and heroin users: relationship to mood, craving, relapse triggers, and cocaine use.

Authors:  Kenzie L Preston; David H Epstein
Journal:  Psychopharmacology (Berl)       Date:  2011-02-12       Impact factor: 4.530

7.  Acceleration by stress of dopamine synthesis and metabolism in prefrontal cortex: antagonism by diazepam.

Authors:  J F Reinhard; M J Bannon; R H Roth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-03       Impact factor: 3.000

8.  The Importance of Titrating Antibodies for Immunocytochemical Methods.

Authors:  Gloria E Hoffman; Kelley J Murphy; Luciane V Sita
Journal:  Curr Protoc Neurosci       Date:  2016-07-01

9.  Footshock and conditioned stress increase 3,4-dihydroxyphenylacetic acid (DOPAC) in the ventral tegmental area but not substantia nigra.

Authors:  A Y Deutch; S Y Tam; R H Roth
Journal:  Brain Res       Date:  1985-04-29       Impact factor: 3.252

10.  Corticotropin-releasing factor increases mouse ventral tegmental area dopamine neuron firing through a protein kinase C-dependent enhancement of Ih.

Authors:  M J Wanat; F W Hopf; G D Stuber; P E M Phillips; A Bonci
Journal:  J Physiol       Date:  2008-02-28       Impact factor: 5.182

View more
  8 in total

Review 1.  Chemogenetics as a neuromodulatory approach to treating neuropsychiatric diseases and disorders.

Authors:  Jingwei Song; Ruchit V Patel; Massoud Sharif; Anagha Ashokan; Michael Michaelides
Journal:  Mol Ther       Date:  2021-12-01       Impact factor: 11.454

2.  Modulation of mGlu5 improves sensorimotor gating deficits in rats neonatally treated with quinpirole through changes in dopamine D2 signaling.

Authors:  Russell W Brown; Christopher G Varnum; Liza J Wills; Loren D Peeters; Justin T Gass
Journal:  Pharmacol Biochem Behav       Date:  2021-10-25       Impact factor: 3.697

3.  Shifts in the neurobiological mechanisms motivating cocaine use with the development of an addiction-like phenotype in male rats.

Authors:  Wendy J Lynch; Anousheh Bakhti-Suroosh; Jean M Abel; Camilla Davis
Journal:  Psychopharmacology (Berl)       Date:  2020-11-25       Impact factor: 4.530

Review 4.  Neurochemical mechanisms and neurocircuitry underlying the contribution of stress to cocaine seeking.

Authors:  Aaron Caccamise; Erik Van Newenhizen; John R Mantsch
Journal:  J Neurochem       Date:  2021-03-22       Impact factor: 5.546

5.  Activating Corticotropin-Releasing Factor Systems in the Nucleus Accumbens, Amygdala, and Bed Nucleus of Stria Terminalis: Incentive Motivation or Aversive Motivation?

Authors:  Hannah M Baumgartner; Jay Schulkin; Kent C Berridge
Journal:  Biol Psychiatry       Date:  2021-01-21       Impact factor: 12.810

6.  CRF-receptor1 modulation of the dopamine projection to prelimbic cortex facilitates cognitive flexibility after acute and chronic stress.

Authors:  David Mor; Serena Becchi; Jeremy Bowring; Madeline Tsoukalas; Bernard W Balleine
Journal:  Neurobiol Stress       Date:  2021-12-24

7.  Cocaine experience abolishes the motivation suppressing effect of CRF in the ventral midbrain.

Authors:  Idaira Oliva; Melissa M Donate; Merridee J Lefner; Matthew J Wanat
Journal:  Addict Biol       Date:  2019-11-12       Impact factor: 4.280

Review 8.  Consideration of sex as a biological variable in the translation of pharmacotherapy for stress-associated drug seeking.

Authors:  Erin L Martin; Elizabeth M Doncheck; Carmela M Reichel; Aimee L McRae-Clark
Journal:  Neurobiol Stress       Date:  2021-07-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.